Cleveland BioLabs
CBLI
#10341
Rank
NZ$87.4 M
Marketcap
NZ$5.65
Share price
-7.31%
Change (1 day)
N/A
Change (1 year)

Earnings for Cleveland BioLabs (CBLI)

Earnings in 2021 (TTM): -NZ$3.97 Million

According to Cleveland BioLabs 's latest financial reports the company's current earnings are NZ$0.63 Million. In 2020 the company made an earning of -NZ$4.58 Million a decrease over its 2019 earnings that were of -NZ$4.21 Million.

Earnings history for Cleveland BioLabs from 2004 to 2021

Annual earnings

Year Earnings Change
2021 (TTM)-NZ$3.97 Million-13.39%
2020-NZ$4.58 Million8.8%
2019-NZ$4.21 Million-50.81%
2018-NZ$8.56 Million-14.3%
2017-NZ$9.98 Million-11.88%
2016-NZ$11.33 Million-50.9%
2015-NZ$23.06 Million-10.24%
2014-NZ$25.69 Million-37.5%
2013-NZ$41.11 Million-23.2%
2012-NZ$53.53 Million19.68%
2011-NZ$44.72 Million133.81%
2010-NZ$19.13 Million68.22%
2009-NZ$11.37 Million-55.51%
2008-NZ$25.56 Million-45.62%
2007-NZ$47 Million255.63%
2006-NZ$13.22 Million198.18%
2005-NZ$4.44 Million-1.25%
2004-NZ$4.49 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
NZ$22.52 B-459,417.87%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Eli Lilly
LLY
NZ$61.93 B-1,263,258.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$19.68 B-401,617.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$13.87 B-283,037.70%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
NZ$20.18 B-411,789.48%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$12.74 B-260,020.58%๐Ÿ‡ฌ๐Ÿ‡ง UK
Soligenix
SNGX
-NZ$20.85 Million 325.20%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
-NZ$0.29 Billion 5,680.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-NZ$32.35 Million 559.60%๐Ÿ‡บ๐Ÿ‡ธ USA